Gene · 3822
Papers2,624
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
121 to 140 of 2,624
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Hypoimmunogenic HLA-E Single Chain Inhibits Alloreactive Immune Responses. | J Immunol | 2024 | 39621955 | PubTator, text mining | PubMed |
| Association Between NK Cell Genetic Variants and the Development of Long COVID Associated- and Prepandemic Small Fiber Neuropathy. | J Med Virol | 2024 | 39610330 | PubTator, text mining | PubMed |
| Nutrient transporter pattern in CD56dim NK cells: CD16 (FcγRIIIA)-dependent modulation and association with memory NK cell functional profile. | Front Immunol | 2024 | 39606236 | PubTator, text mining | PubMed |
| Generation, Characterization, and Preclinical Studies of a Novel NKG2A-Targeted Antibody BRY805 for Cancer Immunotherapy. | Antibodies (Basel) | 2024 | 39584993 | PubTator, text mining | PubMed |
| NKG2C Sequence Polymorphism Modulates the Expansion of Adaptive NK Cells in Response to Human CMV. | HLA | 2024 | 39581700 | PubTator, text mining | PubMed |
| First Longitudinal Analysis of the Immunological Mechanism at Play in Uterus Transplantation. | Transplant Direct | 2024 | 39563727 | PubTator, text mining | PubMed |
| Potential molecular mechanisms of ETV6-RUNX1-positive B progenitor cell cluster in acute lymphoblastic leukemia revealed by single-cell RNA sequencing. | PeerJ | 2024 | 39498293 | PubTator, text mining | PubMed |
| Lesional senescent CD4+ T cells mediate bystander cytolysis and contribute to the skin pathology of human cutaneous leishmaniasis. | Front Immunol | 2024 | 39497830 | PubTator, text mining | PubMed |
| NKG2C and NKG2A coexpression defines a highly functional antiviral NK population in spontaneous HIV control. | JCI Insight | 2024 | 39288262 | PubTator, text mining | PubMed |
| NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma. | J Immunother Cancer | 2024 | 39214651 | PubTator, text mining | PubMed |
| Engineered NKG2C + NK-like T cells exhibit superior antitumor efficacy while mitigating cytokine release syndrome. | bioRxiv | 2024 | 39211122 | PubTator, text mining | PubMed |
| Polygenic polymorphism is associated with NKG2A repertoire and influences lymphocyte phenotype and function. | Blood Adv | 2024 | 39158076 | PubTator, text mining | PubMed |
| Cytomegalovirus immunity in high-risk liver transplant recipients following preemptive antiviral therapy versus prophylaxis. | JCI Insight | 2024 | 39099206 | PubTator, text mining | PubMed |
| Natural Killer Cell Presence in Antibody-Mediated Rejection. | Transpl Int | 2024 | 38979120 | PubTator, text mining | PubMed |
| Adaptive natural killer cell expression in response to cytomegalovirus infection in blood and solid cancer. | Heliyon | 2024 | 38961938 | PubTator, text mining | PubMed |
| BCG priming followed by a novel interleukin combination activates Natural Killer cells to selectively proliferate and become anti-tumour long-lived effectors. | Sci Rep | 2024 | 38849432 | PubTator, text mining | PubMed |
| Pharmacogenomics of coronary artery response to intravenous gamma globulin in kawasaki disease. | NPJ Genom Med | 2024 | 38816462 | PubTator, text mining | PubMed |
| SARS-CoV-2 infection induces adaptive NK cell responses by spike protein-mediated induction of HLA-E expression. | Emerg Microbes Infect | 2024 | 38804979 | PubTator, text mining | PubMed |
| Characterization of Natural Killer Cell Profile in a Cohort of Infected Pregnant Women and Their Babies and Its Relation to CMV Transmission. | Viruses | 2024 | 38793661 | PubTator, text mining | PubMed |
| Multifactorial determinants of NK cell repertoire organization: insights into age, sex, KIR genotype, HLA typing, and CMV influence. | Front Immunol | 2024 | 38736873 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3822/papers?page=7